Pulse Biosciences Inc (PLSE)
11.19
+0.18
(+1.63%)
USD |
NASDAQ |
Jun 28, 16:00
11.21
+0.02
(+0.18%)
Pre-Market: 20:00
Pulse Biosciences Cash from Operations (Quarterly): -9.78M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.78M |
| December 31, 2023 | -6.782M |
| September 30, 2023 | -10.49M |
| June 30, 2023 | -9.202M |
| March 31, 2023 | -6.57M |
| December 31, 2022 | -7.965M |
| September 30, 2022 | -10.63M |
| June 30, 2022 | -12.82M |
| March 31, 2022 | -15.59M |
| December 31, 2021 | -12.69M |
| September 30, 2021 | -13.35M |
| June 30, 2021 | -16.37M |
| March 31, 2021 | -11.69M |
| December 31, 2020 | -9.255M |
| September 30, 2020 | -8.549M |
| June 30, 2020 | -7.939M |
| March 31, 2020 | -9.622M |
| December 31, 2019 | -9.196M |
| September 30, 2019 | -7.965M |
| Date | Value |
|---|---|
| June 30, 2019 | -9.694M |
| March 31, 2019 | -7.33M |
| December 31, 2018 | -6.308M |
| September 30, 2018 | -6.85M |
| June 30, 2018 | -5.72M |
| March 31, 2018 | -5.018M |
| December 31, 2017 | -3.963M |
| September 30, 2017 | -3.417M |
| June 30, 2017 | -1.208M |
| March 31, 2017 | -2.499M |
| December 31, 2016 | -2.318M |
| September 30, 2016 | -1.982M |
| June 30, 2016 | -2.289M |
| March 31, 2016 | -1.462M |
| December 31, 2015 | -1.33M |
| September 30, 2015 | -0.948M |
| June 30, 2015 | -0.582M |
| March 31, 2015 | -0.457M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.37M
Minimum
Jun 2021
-6.57M
Maximum
Mar 2023
-10.34M
Average
-9.622M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Align Technology Inc | 28.66M |
| NeuroOne Medical Technologies Corp | -2.175M |
| SINTX Technologies Inc | -2.733M |
| Nutriband Inc | -0.8339M |
| enVVeno Medical Corp | -3.549M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.005M |
| Cash from Financing (Quarterly) | 0.305M |
| Free Cash Flow | -36.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1774 |
| Free Cash Flow Yield | -6.19% |